Broad-spectrum therapeutic

Avicanna Reports Q3 2023 Results

Retrieved on: 
Tuesday, November 14, 2023

TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of proprietary cannabinoid-based products and medical cannabis care platform is pleased to announce the results of Q3 2023.

Key Points: 
  • TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of proprietary cannabinoid-based products and medical cannabis care platform is pleased to announce the results of Q3 2023.
  • A 9-month revenue of $10.7M, representing a major milestone in the Company’s history a 269% growth from the same period last year.
  • Scalability of the business model was demonstrated with a comparable increase of 23% in SG&A for the nine-month period.
  • Access to the Company’s proprietary medical products improved for patients with availability on new medical platforms such as Canna Farms and Spectrum Therapeutics.

Canopy Growth to Report Second Quarter Fiscal 2023 Financial Results on November 9, 2022

Retrieved on: 
Thursday, October 27, 2022

Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany.

Key Points: 
  • Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany.
  • Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.
  • Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments.
  • Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements.

Ace Valley Celebrates Sex Positivity with Debut of Lust and Thrust Cannabis Infused Gummies

Retrieved on: 
Friday, October 21, 2022

The flavours of Lust and Thrust aim to enhance both solo and partnered play via delicious bite-sized gummies and aspire to make good sex greater.

Key Points: 
  • The flavours of Lust and Thrust aim to enhance both solo and partnered play via delicious bite-sized gummies and aspire to make good sex greater.
  • Ace Valley Lust Cherry Rose Gummies feature a juicy flavour, botanical extracts and are infused with 25mg of CBD and 2.5mg of THC per gummy, with the sweet, yet delicate, taste of cherry and rose blossoms.
  • "Ace Valley celebrates sex positivity, including those who are already combining cannabis and sex, as well as those who are curious about it," said Tara Rozalowsky, Vice President, Brand Marketing.
  • Ace Valley Lust and Thrust gummies are available for purchase via legal recreational cannabis e-commerce channels and retail locations in select regions.

Canopy Growth Announces Results of Annual General and Special Shareholder Meeting

Retrieved on: 
Friday, September 16, 2022

Canopy Growth shareholders also approved the re-appointment of KPMG LLP as the Company's auditors for the 2023 fiscal year and authorized the board of directors to fix its remuneration.

Key Points: 
  • Canopy Growth shareholders also approved the re-appointment of KPMG LLP as the Company's auditors for the 2023 fiscal year and authorized the board of directors to fix its remuneration.
  • In addition, Canopy Growth shareholders approved the renewal of the Company's Employee Stock Purchase Plan.
  • Canopy Growth shareholders also approved an advisory (non-binding) resolution on the compensation of the Company's named executive officers.
  • Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.

Storz & Bickel Debuts "with Love, for Peace" Limited-Edition VOLCANO CLASSIC

Retrieved on: 
Thursday, September 8, 2022

TUTTLINGEN, Germany, Sept. 8, 2022 /PRNewswire/ - STORZ & BICKEL GmbH ("STORZ & BICKEL"), a world-leading manufacturer of high-end and medically certified cannabis vaporizers and subsidiary of Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), today unveiled a limited-edition version of its flagship VOLCANO CLASSIC device: the PEACE VOLCANO.

Key Points: 
  • TUTTLINGEN, Germany, Sept. 8, 2022 /PRNewswire/ - STORZ & BICKEL GmbH ("STORZ & BICKEL"), a world-leading manufacturer of high-end and medically certified cannabis vaporizers and subsidiary of Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), today unveiled a limited-edition version of its flagship VOLCANO CLASSIC device: the PEACE VOLCANO.
  • Only 1,000 units of the PEACE VOLCANO are being made, with each device engraved with number 1 to 1,000.
  • As a part of the "with Love, for Peace" campaign, STORZ & BICKEL is donating 100 per unit produced, a total of 100,000, to charity organizations.
  • The PEACE VOLCANO is now available for purchase while supplies last and is offered at the regular VOLCANO CLASSIC price of $479 USD.

Limited-Edition Pumpkin Spice CBD Wellness Gummies™ Arrive Just in Time for Fall As Martha Stewart CBD Expands Portfolio

Retrieved on: 
Monday, August 15, 2022

SMITHS FALLS, ON and NEW YORK, Aug. 15, 2022 /PRNewswire/ - Today, Martha Stewart CBD unveiled the latest flavor in its CBD portfolio Pumpkin Spice CBD Wellness Gummies.

Key Points: 
  • SMITHS FALLS, ON and NEW YORK, Aug. 15, 2022 /PRNewswire/ - Today, Martha Stewart CBD unveiled the latest flavor in its CBD portfolio Pumpkin Spice CBD Wellness Gummies.
  • These limited-edition gummies continue the expansion of the Martha Stewart CBD gummies lineup, which features some of the brands most popular items and flavors, including the Tropical Medley CBD Wellness Gummies and Harvest Medley CBD Wellness Gummies.
  • "The Pumpkin Spice flavor signifies the beginning of the fall season and I wanted to capture this delicious moment with our CBD gummies," said Martha Stewart.
  • Debuting this week for $34.99 on marthastewartcbd.com, the limited-edition Pumpkin Spice CBD Wellness Gummies were developed by Martha herself, and each Wellness Gummy features exquisite texture and 10mg of pure CBD isolate.

Canopy Growth Announces Industry Veteran Christelle Gedeon As New Chief Legal Officer

Retrieved on: 
Tuesday, August 2, 2022

SMITHS FALLS, ON, Aug. 2, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, is pleased to announce that the appointment of Christelle Gedeon, Ph.D., as the Company's new Chief Legal Officer.

Key Points: 
  • SMITHS FALLS, ON, Aug. 2, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, is pleased to announce that the appointment of Christelle Gedeon, Ph.D., as the Company's new Chief Legal Officer.
  • I am confident that Christelle's commercial and legal acumen will be key to further bringing our strategy to fruition."
  • In addition to her demonstrated expertise in the cannabis industry, Christelle brings experience with complex regulatory structures, intellectual property management, corporate governance, government relations, and strategic acquisitions.
  • Her appointment to the role of Chief Legal Officer at Canopy Growth is effective immediately.

CANOPY GROWTH ANNOUNCES NEW PREMIUM FLOWER LINE-UP PERFECT FOR SUMMER STAYCATIONS AND WEEKENDS AWAY

Retrieved on: 
Thursday, July 28, 2022

Perfect for both staycations and weekends away, the new premium flower offerings from 7ACRES and Doja demonstrate Canopy Growth's commitment to continued innovation and strengthen its leading position in the premium flower category.

Key Points: 
  • Perfect for both staycations and weekends away, the new premium flower offerings from 7ACRES and Doja demonstrate Canopy Growth's commitment to continued innovation and strengthen its leading position in the premium flower category.
  • With these new releases, Canopy expands its premium flower options that deliver on the quality, genetics, and innovation that cannabis connoisseurs demand.
  • "Cannabis connoisseurs know what they want: premium products that over-deliver on aroma and flavour, while still hitting the THC mark," said Julian Cohen, Chief Innovation Officer at Canopy Growth.
  • Leveraging consumer insights and innovation, Canopy Growth offers product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel.

Canopy Growth to Report First Quarter Fiscal 2023 Financial Results on August 5, 2022

Retrieved on: 
Friday, July 22, 2022

Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany.

Key Points: 
  • Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany.
  • Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.
  • Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments.
  • Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements.

Canopy Growth Announces Closing of Previously Announced Exchange Transaction

Retrieved on: 
Tuesday, July 19, 2022

SMITHS FALLS, ON, July 18, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that it has closed (the "Final Closing") its previously announced exchange transaction (the "Transaction") of certain 4.25% unsecured notes due 2023 (the "Notes") in order to reduce its debt obligations by approximately $263 million.

Key Points: 
  • SMITHS FALLS, ON, July 18, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that it has closed (the "Final Closing") its previously announced exchange transaction (the "Transaction") of certain 4.25% unsecured notes due 2023 (the "Notes") in order to reduce its debt obligations by approximately $263 million.
  • In addition, on the Final Closing, 29,245,456 Canopy Shares were issued to GCILP based on a price per Canopy Share equal to the Averaging Price.
  • Upon completion of the Transaction, CBI, though GCILP and CBG Holdings LLC, holds 171,499,258 Canopy Shares, representing approximately 35.7% of the issued and outstanding Canopy Shares on a non-diluted basis.
  • HudsonWest LLC and BMO Capital Markets acted as financial advisors and exchange agents to Canopy Growth.